ASCEND BY NTHRYS
Research Abroad Products

Regulomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 121–132 of 200 project topics
AI-Powered Transcription Factor Binding Site Prediction Platform
A machine learning SaaS platform that predicts transcription factor binding sites across cancer genomes using deep learning models trained on ChIP-seq data. This enables pharma companies to rapidly identify novel regulatory vulnerabilities and prioritize drug targets, reducing discovery timelines by 40-60% and accelerating lead compound identification.
Cancer Regulomics Drug Target Discovery Click to view more details →
Cancer-Specific Enhancer Mapping and Validation as a Service
A commercial platform that integrates ATAC-seq, Hi-C, and RNA-seq data to map cancer-type-specific enhancers and their target genes through automated bioinformatic pipelines. Biotech firms leverage this service to uncover tissue-specific dependencies and validate regulatory mechanisms, creating competitive advantages in target selection and reducing failed clinical programs.
Cancer Regulomics Drug Target Discovery Click to view more details →
Real-Time Chromatin Accessibility Profiling Technology for Drug Screening
An integrated lab-on-chip device and software suite that measures dynamic chromatin remodeling changes in response to drug exposure in real-time using impedance sensing. This provides pharmaceutical companies with functional validation of regulatory pathway engagement, accelerating compound prioritization and reducing attrition in preclinical development.
Cancer Regulomics Drug Target Discovery Click to view more details →
Mutation-Driven Transcriptional Rewiring Database and Query Engine
A comprehensive SaaS database indexing how cancer-associated mutations alter transcription factor activity, chromatin accessibility, and gene expression across 50+ cancer types with real-time query capabilities. Biotech and pharmaceutical teams use this to rapidly map mutant-specific regulatory dependencies and identify synthetic lethal vulnerabilities for targeted drug development.
Cancer Regulomics Drug Target Discovery Click to view more details →
Super-Enhancer Addiction Prediction Model for Oncology Drug Discovery
A proprietary computational platform that predicts cancer cell dependence on specific super-enhancers and their associated oncogenes using machine learning and multi-omics integration. This tool delivers 3-5x higher hit rates in virtual screening campaigns and enables precision targeting of undruggable transcription factors through bromodomain and chromatin modulator therapeutics.
Cancer Regulomics Drug Target Discovery Click to view more details →
Patient-Derived Regulome Profiling Service for Precision Oncology
A clinical-grade laboratory service that performs comprehensive regulomic profiling on patient tumor samples, delivering personalized transcriptional dependency maps and regulatory biomarkers within 2-3 weeks. This enables companion diagnostic opportunities, patient stratification for clinical trials, and premium reimbursement pathways for precision oncology therapeutics.
Cancer Regulomics Drug Target Discovery Click to view more details →
Epigenetic Plasticity and Drug Resistance Prediction Analytics Platform
A SaaS analytics platform that predicts how tumors will epigenetically reprogram under drug pressure by modeling chromatin dynamics and transcriptional state transitions using single-cell regulomics data. Pharmaceutical companies use this to design combination therapy strategies and identify resistance vulnerabilities, increasing clinical success rates and enabling premium pricing for next-generation oncology drugs.
Cancer Regulomics Drug Target Discovery Click to view more details →
Noncoding Variant Functional Impact Scoring System for Cancer Genomics
A bioinformatic software suite that assigns functional impact scores to noncoding variants in regulatory regions by integrating epigenetic marks, conservation metrics, and machine learning classifiers. This enables contract research organizations and biotech firms to identify driver regulatory mutations with 85%+ precision, unlocking novel pathways for drug target discovery.
Cancer Regulomics Drug Target Discovery Click to view more details →
Temporal Regulome Tracking Platform for Treatment Response Monitoring
A longitudinal monitoring platform that tracks changes in tumor regulomes throughout treatment courses using liquid biopsy-derived circulating tumor DNA and chromatin profiling technologies. This delivers real-time treatment response biomarkers and resistance mechanism detection, enabling adaptive trial designs and creating opportunities for companion diagnostic commercialization.
Cancer Regulomics Drug Target Discovery Click to view more details →
Synthetic Lethal Regulator Discovery Engine Using CRISPR Perturbomics
A high-throughput discovery platform combining multiplexed CRISPR screening with regulomic readouts to systematically identify synthetic lethal relationships between transcriptional regulators and cancer mutations. This generates proprietary target portfolios for pharmaceutical development and enables licensing opportunities, with each validated regulator representing 8-12 figure deal potential.
Cancer Regulomics Drug Target Discovery Click to view more details →
Gene Regulatory Network Prediction SaaS Platform
A cloud-based platform that uses machine learning to predict transcription factor binding sites and gene regulatory networks in crop genomes. Enables breeders to identify and stack beneficial regulatory variants, reducing breeding cycles by 40-60% and accelerating time-to-market for improved crop varieties.
Plant Regulomics Crop Improvement Platforms Click to view more details →
Promoter Engineering Optimization Software Suite
Commercial software that designs and optimizes synthetic promoters tailored to specific crop species and environmental conditions using regulomic databases. Delivers 2-3x higher transgene expression consistency, enabling premium seed licensing and trait stacking services worth $5-15M annually per crop.
Plant Regulomics Crop Improvement Platforms Click to view more details →